NeoStem Inc Stock Nyse
Equities
NBS
US6406503051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 20 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 20 | Lisata Therapeutics Receives European Medicines Agency Pediatric Waiver for Pancreatic Cancer Treatment | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27.08M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.06
x | P/E ratio 2025 * |
-1.21
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.21% |
Latest transcript on NeoStem Inc
1st Jan change | Capi. | |
---|---|---|
+48.62% | 57.87B | |
+41.65% | 40.25B | |
-7.40% | 39.94B | |
-5.96% | 28.54B | |
+12.24% | 26.4B | |
-20.23% | 19.33B | |
+30.22% | 12.4B | |
-0.70% | 12.23B | |
+24.68% | 12.2B |
- Stock Market
- Equities
- LSTA Stock
- NBS Stock